150 related articles for article (PubMed ID: 24731709)
1. Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses.
Boanini E; Torricelli P; Gazzano M; Della Bella E; Fini M; Bigi A
Biomaterials; 2014 Jul; 35(21):5619-26. PubMed ID: 24731709
[TBL] [Abstract][Full Text] [Related]
2. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
Biomaterials; 2012 Jan; 33(2):722-30. PubMed ID: 22014461
[TBL] [Abstract][Full Text] [Related]
3. Strontium and zoledronate hydroxyapatites graded composite coatings for bone prostheses.
Boanini E; Torricelli P; Sima F; Axente E; Fini M; Mihailescu IN; Bigi A
J Colloid Interface Sci; 2015 Jun; 448():1-7. PubMed ID: 25706198
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells.
Capuccini C; Torricelli P; Boanini E; Gazzano M; Giardino R; Bigi A
J Biomed Mater Res A; 2009 Jun; 89(3):594-600. PubMed ID: 18437694
[TBL] [Abstract][Full Text] [Related]
5. Sr-containing hydroxyapatite: morphologies of HA crystals and bioactivity on osteoblast cells.
Aina V; Bergandi L; Lusvardi G; Malavasi G; Imrie FE; Gibson IR; Cerrato G; Ghigo D
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1132-42. PubMed ID: 23827552
[TBL] [Abstract][Full Text] [Related]
6. Systematic strontium substitution in hydroxyapatite coatings on titanium via micro-arc treatment and their osteoblast/osteoclast responses.
Chung CJ; Long HY
Acta Biomater; 2011 Nov; 7(11):4081-7. PubMed ID: 21784178
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
[TBL] [Abstract][Full Text] [Related]
8. The effect of alendronate doped calcium phosphates on bone cells activity.
Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
Bone; 2012 Nov; 51(5):944-52. PubMed ID: 22878156
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of strontium-substituted hydroxyapatite nanoparticles for bone regeneration.
Frasnelli M; Cristofaro F; Sglavo VM; Dirè S; Callone E; Ceccato R; Bruni G; Cornaglia AI; Visai L
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():653-662. PubMed ID: 27987756
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast-osteoclast-endothelial cell co-culture study.
Forte L; Torricelli P; Boanini E; Gazzano M; Rubini K; Fini M; Bigi A
Acta Biomater; 2016 Mar; 32():298-308. PubMed ID: 26689470
[TBL] [Abstract][Full Text] [Related]
11. The effects of zoledronate on the survival and function of human osteoblast-like cells.
Huang KC; Cheng CC; Chuang PY; Yang TY
BMC Musculoskelet Disord; 2015 Nov; 16():355. PubMed ID: 26572124
[TBL] [Abstract][Full Text] [Related]
12. Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics.
Xue W; Moore JL; Hosick HL; Bose S; Bandyopadhyay A; Lu WW; Cheung KM; Luk KD
J Biomed Mater Res A; 2006 Dec; 79(4):804-14. PubMed ID: 16886220
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of trace element Si and Sr codoping hydroxyapatite with non-cytotoxicity and enhanced cell proliferation and differentiation.
Gao J; Wang M; Shi C; Wang L; Wang D; Zhu Y
Biol Trace Elem Res; 2016 Nov; 174(1):208-217. PubMed ID: 27075548
[TBL] [Abstract][Full Text] [Related]
14. Effects of strontium on the physicochemical characteristics of hydroxyapatite.
Verberckmoes SC; Behets GJ; Oste L; Bervoets AR; Lamberts LV; Drakopoulos M; Somogyi A; Cool P; Dorriné W; De Broe ME; D'Haese PC
Calcif Tissue Int; 2004 Nov; 75(5):405-15. PubMed ID: 15592797
[TBL] [Abstract][Full Text] [Related]
15. Effects of strontium in modified biomaterials.
Zhang W; Shen Y; Pan H; Lin K; Liu X; Darvell BW; Lu WW; Chang J; Deng L; Wang D; Huang W
Acta Biomater; 2011 Feb; 7(2):800-8. PubMed ID: 20826233
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
17. Strontium-substituted hydroxyapatite coatings deposited via a co-deposition sputter technique.
Boyd AR; Rutledge L; Randolph LD; Meenan BJ
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():290-300. PubMed ID: 25491990
[TBL] [Abstract][Full Text] [Related]
18. Experimental and simulation studies of strontium/fluoride-codoped hydroxyapatite nanoparticles with osteogenic and antibacterial activities.
Wang Q; Li P; Tang P; Ge X; Ren F; Zhao C; Fang J; Wang K; Fang L; Li Y; Bao C; Lu X; Duan K
Colloids Surf B Biointerfaces; 2019 Oct; 182():110359. PubMed ID: 31352253
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
20. Murine osteoblastic and osteoclastic differentiation on strontium releasing hydroxyapatite forming cements.
Singh SS; Roy A; Lee B; Parekh S; Kumta PN
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():429-38. PubMed ID: 27040237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
